[TTF-1 expression and its diagnostic application in lung carcinomas]

Area of Science:

• Oncology
• Pathology
• Immunohistochemistry

Background:

• Thyroid transcription factor 1 (TTF-1) is a homeodomain protein crucial for the development of thyroid and lung tissues.
• Accurate diagnosis of lung carcinomas is essential for effective treatment and patient prognosis.
• Distinguishing primary lung cancers from metastatic tumors and other malignancies can be challenging.

Purpose of the Study:

• To evaluate the expression of TTF-1 in various lung carcinoma types.
• To assess the utility of TTF-1 as a diagnostic marker in lung cancer.
• To differentiate primary lung adenocarcinomas and small cell lung cancers from other tumors.

Main Methods:

• Immunohistochemistry was employed to detect TTF-1 expression in 134 lung lobectomy specimens.
• Specimens included primary lung carcinomas (NSCLC, SCLC) and metastatic carcinomas.
• TTF-1 expression levels were quantitatively assessed and categorized.

Main Results:

• TTF-1 showed high positive expression in small cell lung cancers (82.1%) and lung adenocarcinomas (73.8%).
• No significant correlation was found between TTF-1 expression and adenocarcinoma differentiation or subtypes.
• Metastatic adenocarcinomas were predominantly TTF-1 positive, with notable exceptions.
• Squamous cell carcinomas, lymphomas, and inflammatory lesions consistently lacked TTF-1 expression.

Conclusions:

• TTF-1 expression is a valuable marker for distinguishing small cell lung cancer from squamous cell carcinoma and non-neoplastic lesions.
• The restricted expression pattern of TTF-1 in lung tissue supports its use in differentiating primary lung adenocarcinoma from metastatic adenocarcinoma.
• TTF-1 immunohistochemistry enhances diagnostic accuracy in lung carcinoma pathology.